Press Releases




No Image

Severn Bancorp, Inc. Announces Third Quarter Earnings

ANNAPOLIS, Md., Oct. 22, 2020 /PRNewswire/ — Severn Bancorp, Inc. (the Company) (NASDAQ: SVBI), the parent company of Severn Bank (the Bank), reported net income of $1.9 million for the third quarter ended September 30, 2020 and $4.2 million for the nine months ended September 30, 2020 compared to $2.4 million and $7.2 million for the same periods in 2019. Earnings per share on a fully diluted basis were $0.15 for the third quarter and $0.33 per share for the first nine months of 2020, down from $0.19 and $0.56 per share, respectively, from the third quarter and first nine months of 2019.


No Image

Redwood Green Corp. Announced Change of Name to Andina Gold Corp. and Ticker Symbol ‘AGOL’

DENVER, Oct. 22, 2020 /PRNewswire/ — Redwood Green Corp. announced that effective immediately the company name is changed to Andina Gold Corp. (OTCQB:AGOL), in keeping with its previous press release announcing changes to the company’s business direction and strategy. Approval from FINRA has also been received to change the company’s ticker symbol, and Andina Gold Corp. will begin trading under the ticker symbol “AGOL” on the OTCQB effective at market open on October 22, 2020. The new CUSIP number associated with the symbol is 034215103. Shareholders are not required to take any action in connection with the change of name.


No Image

NUG Introduces The First-Ever Inhalable CBN Product Line to the California Cannabis Market

OAKLAND, Calif., Oct. 22, 2020 /PRNewswire/ — NUG (the “Company” or “NUG”) a leading vertically integrated California producer of cannabis concentrates, edibles, and flower, is pleased to introduce the first-ever verified inhalable CBN product line to the California legal cannabis market. The new CBN product line will consist of the first-ever CBN/THCA Sugar and CBN/THCA Infused Pre-Roll.



Green Flower Teams with New Florida University Partner to Offer Online Cannabis Certificate Programs

VENTURA, Calif., Oct. 8, 2020 /PRNewswire/ — Green Flower, the world’s leading education provider for cannabis, announced the inaugural launch of professionally developed, non-credit certificate programs in partnership with Florida Atlantic University Center for Online and Continuing Education, their seventh university partner. The innovative, six-month programs prepare professionals to fill the growing skills gap in the legalized cannabis industry.


Curaleaf Announces Upcoming Investor Conference Participation

WAKEFIELD, Mass., Sept. 28, 2020 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, today announced management is scheduled to participate in the following upcoming investor conference events:


Legalization Efforts Continue to Drive the Cannabis Market Growth

NEW YORK, Sept. 25, 2020 /PRNewswire/ — The legalization of cannabis in several countries is one of the key factors driving the market’s growth. In addition, the use of cannabis for medical purposes is gaining momentum worldwide. Medical cannabis products are used for the treatment of various chronic conditions such as cancer, arthritis, and neurological conditions, as well as anxiety, depression, epilepsy, as well as Parkinson’s and Alzheimer’s disease. This year, the elections across the country will help determine the future of cannabis products in several states and could have an influence on the federal legalization in the future. According to Leafy, six states will be voting on legalization this November, with four states are voting on adult-use (recreational) cannabis legalization: Arizona, Montana, New Jersey, and South Dakota. Two states are voting on medical marijuana legalization: Mississippi, and South Dakota. Oregon voters will consider two separate drug reform measures. One would legalize the medical use of psilocybin. The other would decriminalize small amounts of all drugs. MediPharm Labs Corp. (OTC: MEDIF) (TSX: LABS), HEXO Corp. (NYSE: HEXO), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), OrganiGram Holdings Inc. (OGI), GW Pharmaceuticals plc (NASDAQ: GWPH)